Austrian enforcer settles predatory pricing probe into Merck
Austria's Federal Competition Authority has accepted commitments from pharmaceutical company Merck Sharp & Dohme's local subsidiary to stop charging predatory prices for a brain tumour drug.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.